- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-587/17: Action brought on 28 August 2017 — Unigroup v EUIPO — Pronova Laboratories (nailicin)
ECLI:EU:UNKNOWN:62017TN0587
62017TN0587
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
16.10.2017
EN
Official Journal of the European Union
C 347/48
(Case T-587/17)
(2017/C 347/63)
Language in which the application was lodged: English
Parties
Applicant: Unigroup ApS (Lyngby, Denmark) (represented by: M. Rijsdijk, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Pronova Laboratories BV (Amsterdam, Netherlands)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Applicant
Trade mark at issue: EU word mark ‘nailicin’ — Application for registration No 14 096 499
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the fifth Board of Appeal of EUIPO of 9 June 2017 in Case R 2359/2016-5
Form of order sought
The applicant claims that the Court should:
—annul the contested decision;
—declare Benelux registration no. 894 557 unsubstantiated and remit the matter to the Opposition Division or Board of Appeal of EUIPO;
—order EUIPO to pay the costs.
Plea in law
—violation of Rule 19 of Commission Regulation No 2868/95 implementing Council Regulation No 40/94 on the Community trade mark.